Skip to main content
Fig. 9 | BMC Cancer

Fig. 9

From: The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity

Fig. 9

Rho Activity assay in primary mouse mammary epithelial cells. a Representative western blot showing the activation of RhoA in primary mammary epithelial cells plus or minus serum addition as described in the materials and methods section. b Bar graph showing the active RhoA levels determined by normalizing the amount of RBD-bound Rho to the total RhoA in whole cell lysates. Data is represented as the mean ± SEM from a total of 6 independent experiments. Statistical analyses were performed using student T test. *p < 0.05; **p < 0.01. [WT - FBS vs WT+FBS, p = 0.04; Dlc1gt/+-FBS vs Dlc1gt/++FBS, p = 0.022; WT-FBS vs Dlc1gt/+ -FBS, p = 0.021; WT+FBS vs Dlc1gt/++FBS, p = 0.0085]

Back to article page